Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand

Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand

Background: Cannabidiol (CBD) is the non-euphoriant component of cannabis. In 2017, the New Zealand Misuse of Drugs Regulations (1977) were amended, allowing doctors to prescribe CBD. Therapeutic benefit and tolerability of CBD remains unclear. Aim: To review the changes in self-reported quality of...

Full description

Bibliographic Details
Main Authors: Graham Gulbransen, William Xu, Bruce Arroll
Format: Article
Language:English
Published: Royal College of General Practitioners 2020-02-01
Series:BJGP Open
Subjects:
community care
therapy in mental health
prescribing
cannabidiol
cannabis
anti-anxiety agents
mental health
depression
chronic pain
analgesics
patient reported outcome measures
Online Access:https://bjgpopen.org/content/4/1/bjgpopen20X101010

Internet

https://bjgpopen.org/content/4/1/bjgpopen20X101010

Similar Items